Imaging Biometrics - Director/PDMR Dealing

Imaging Biometrics

09/07/2025 17:14

RNS Number : 4320Q

Imaging Biometrics Limited

09 July 2025

 

Imaging Biometrics Limited

("IB" or the "Company")

 

PDMR dealing

 

Imaging Biometrics Limited, a leader in quantitative imaging solutions and novel therapies for CNS malignancies, announces that it has been notified of the following transactions in ordinary shares in the Company undertaken by directors/persons discharging managerial responsibility (PDMR).

 

The notification below is made in accordance with Article 19(3) of the Market Abuse Regulation.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Michael Schmainda
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)
Name
Imaging Biometrics, Ltd
b)
LEI
213800SPW48XRJS2QH57
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.01 each in Imaging Biometrics, Ltd
Identification code
JE00BD4H0R42
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
0.7 pence
200,000 Ordinary Shares
d)
Aggregated information
- Aggregated volume
200,000
- Price
£1400
e)
Date of the transaction
09/07/2025
f)
Place of the transaction
London Stock Exchange (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHEAKXNEFASEFA